Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitis
Open Access
- 9 March 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Interleukin-2-inducible T cell kinase is expressed by T cells and amplifies T cell receptor-dependent signals. Interleukin-2-inducible T cell kinase deletion or inhibition reduces production of interleukin-4 and interleukin-13, key drivers of atopic dermatitis. Nerve growth factor signals via the receptor tropomyosin-related kinase A and may promote pruritus in atopic dermatitis lesions. Here we describe PF-07245303, a compound which potently inhibits interleukin-2-inducible T cell kinase and tropomyosin-related kinase family kinases capable of inhibiting T cell receptor-mediated cytokine production from CD4 and CD8 T cells and suppressing nerve growth factor-induced human basophil activation. In human skin explants, PF-07245303 demonstrates inhibition of tropomyosin-related kinase A phosphorylation, suppresses cytokine expression from T cell receptor-activated resident T cells and reverses the expression of atopic dermatitis associated genes. Topical application of PF-07245303 reduces proinflammatory and epidermal changes in a dermatitis model using female mice. By inhibiting both pathogenic inflammatory mechanisms, PF-07245303 may have therapeutic value for patients with atopic dermatitis.Keywords
This publication has 83 references indexed in Scilit:
- What’s New in Topicals for Atopic Dermatitis?American Journal of Clinical Dermatology, 2022
- Topical drug delivery: History, percutaneous absorption, and product developmentAdvanced Drug Delivery Reviews, 2021
- Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesisJournal of Molecular Medicine, 2020
- Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic DermatitisJAMA Dermatology, 2020
- T cell pathology in skin inflammationSeminars in Immunopathology, 2019
- Allele‐sensitive mutant, Itkas, reveals that Itk kinase activity is required for Th1, Th2, Th17, and iNKT‐cell cytokine productionEuropean Journal of Immunology, 2015
- Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Clinical Reviews in Allergy & Immunology, 2015
- Development of a new permeability assay using low‐efflux MDCKII cellsJournal of Pharmaceutical Sciences, 2011
- ggplot22009
- A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discoveryRapid Communications in Mass Spectrometry, 2004